|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
1/31/2008 8:54:27 AM
STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News:
As of 31 January 2008, the number of shares in Meda AB (STO:MEDAA) is 259,065,485, which constitutes a 2,386,134 increase in shares compared with the previous month. The increase is due to newly issued shares via redemption of warrants, exercised primarily by Stena Sessan Rederi AB. After the warrants redemption, the Stena Sessan Group's 1) shareholding rose to 67,151,652, which is comparable to 25.9% of Meda's share capital and votes. An additional 905,432 new shares can be subscribed for via redemption of warrants. If fully exercised, the dilution effect of Meda's share capital and votes is 0.03%. The warrant program ends on 26 February 2008.
|
|
|
|
|
|
|
|
|
|
|